UniProt ID | S35G2_HUMAN | |
---|---|---|
UniProt AC | Q8TBE7 | |
Protein Name | Solute carrier family 35 member G2 {ECO:0000312|HGNC:HGNC:28480} | |
Gene Name | SLC35G2 {ECO:0000312|HGNC:HGNC:28480} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 412 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein . |
|
Protein Description | May play a role in cell proliferation.. | |
Protein Sequence | MDTSPSRKYPVKKRVKIHPNTVMVKYTSHYPQPGDDGYEEINEGYGNFMEENPKKGLLSEMKKKGRAFFGTMDTLPPPTEDPMINEIGQFQSFAEKNIFQSRKMWIVLFGSALAHGCVALITRLVSDRSKVPSLELIFIRSVFQVLSVLVVCYYQEAPFGPSGYRLRLFFYGVCNVISITCAYTSFSIVPPSNGTTMWRATTTVFSAILAFLLVDEKMAYVDMATVVCSILGVCLVMIPNIVDEDNSLLNAWKEAFGYTMTVMAGLTTALSMIVYRSIKEKISMWTALFTFGWTGTIWGISTMFILQEPIIPLDGETWSYLIAICVCSTAAFLGVYYALDKFHPALVSTVQHLEIVVAMVLQLLVLHIFPSIYDVFGGVIIMISVFVLAGYKLYWRNLRKQDYQEILDSPIK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MDTSPSRKYP -----CCCCCCCCCC | 41.04 | 28355574 | |
4 | Phosphorylation | ----MDTSPSRKYPV ----CCCCCCCCCCC | 19.33 | 22199227 | |
6 | Phosphorylation | --MDTSPSRKYPVKK --CCCCCCCCCCCCC | 40.97 | 22199227 | |
9 | Phosphorylation | DTSPSRKYPVKKRVK CCCCCCCCCCCCCEE | 16.49 | 24260401 | |
26 | Phosphorylation | PNTVMVKYTSHYPQP CCEEEEEEECCCCCC | 11.32 | 28796482 | |
27 | Phosphorylation | NTVMVKYTSHYPQPG CEEEEEEECCCCCCC | 11.87 | 28796482 | |
28 | Phosphorylation | TVMVKYTSHYPQPGD EEEEEEECCCCCCCC | 20.24 | 28796482 | |
30 | Phosphorylation | MVKYTSHYPQPGDDG EEEEECCCCCCCCCC | 11.88 | 25884760 | |
38 | Phosphorylation | PQPGDDGYEEINEGY CCCCCCCHHHHHHCC | 19.86 | 28796482 | |
45 | Phosphorylation | YEEINEGYGNFMEEN HHHHHHCCCCCCHHC | 11.61 | 28796482 | |
54 | Ubiquitination | NFMEENPKKGLLSEM CCCHHCCCCCHHHHH | 71.68 | 23503661 | |
55 | Ubiquitination | FMEENPKKGLLSEMK CCHHCCCCCHHHHHH | 56.92 | 32142685 | |
55 | Acetylation | FMEENPKKGLLSEMK CCHHCCCCCHHHHHH | 56.92 | 30593005 | |
59 | Phosphorylation | NPKKGLLSEMKKKGR CCCCCHHHHHHHHCC | 40.46 | 25159151 | |
62 | Acetylation | KGLLSEMKKKGRAFF CCHHHHHHHHCCCCC | 47.48 | 30593011 | |
63 | Acetylation | GLLSEMKKKGRAFFG CHHHHHHHHCCCCCC | 60.18 | 30592999 | |
92 | Phosphorylation | NEIGQFQSFAEKNIF CCHHHHHHHHHHCHH | 27.93 | 24719451 | |
96 | Ubiquitination | QFQSFAEKNIFQSRK HHHHHHHHCHHCCCC | 52.49 | 23503661 | |
147 | Phosphorylation | RSVFQVLSVLVVCYY HHHHHHHHHHHHHHH | 17.97 | 24719451 | |
258 | Phosphorylation | AWKEAFGYTMTVMAG HHHHHHCCHHHHHHH | 6.20 | 22210691 | |
259 | Phosphorylation | WKEAFGYTMTVMAGL HHHHHCCHHHHHHHH | 13.52 | 22210691 | |
277 | Phosphorylation | LSMIVYRSIKEKISM HHHHHHHHHHHHHHH | 21.96 | 22210691 | |
403 | Phosphorylation | RNLRKQDYQEILDSP HHHCHHHHHHHHCCC | 12.92 | 28796482 | |
409 | Phosphorylation | DYQEILDSPIK---- HHHHHHCCCCC---- | 25.69 | 30266825 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of S35G2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of S35G2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of S35G2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TGFB1_HUMAN | TGFB1 | physical | 26186194 | |
DCC1_HUMAN | DSCC1 | physical | 26186194 | |
CHRC1_HUMAN | CHRAC1 | physical | 28514442 | |
DCC1_HUMAN | DSCC1 | physical | 28514442 | |
DDX23_HUMAN | DDX23 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409, AND MASSSPECTROMETRY. |